Clinical Trials Browser

Phase 3 × Multiple Myeloma × valspodar × Clear all

NCT00002878 2023-06-15

Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 3 Completed

Multiple Myeloma, Neoplasms, Plasma Cell